Lipoamide Dehydrogenase (LADH) Deficiency: Medical Perspectives of the Structural and Functional Characterization of LADH and Its Pathogenic Variants

Overview

Journal Biol Futur

Specialty Biology

Date 2023 Feb 26

PMID 36842090

Authors

Eszter Szabo

Attila Ambrus

Affiliations

Soon will be listed here.

Abstract

(Dihydro)lipoamide dehydrogenase (LADH) deficiency is an autosomal recessive genetic metabolic disorder. It generally presents with an onset in the neonatal age and premature death. The clinical picture usually involves metabolic decompensation and lactic acidosis that lead to neurological, cardiological, and/or hepatological outcomes. Severity of the disease is due to the fact that LADH is a common E3 subunit to the pyruvate, alpha-ketoglutarate, alpha-ketoadipate, and branched-chain alpha-keto acid dehydrogenase complexes and is also part of the glycine cleavage system; hence, a loss in LADH activity adversely affects several central metabolic pathways simultaneously. The severe clinical manifestations, however, often do not parallel the LADH activity loss, which implies the existence of auxiliary pathological pathways; stimulated reactive oxygen species (ROS) production as well as dissociation from the relevant multienzyme complexes proved to be auxiliary exacerbating pathomechanisms for selected disease-causing LADH mutations. This review provides an overview on the therapeutic challenges of inherited metabolic diseases, structural and functional characteristics of the mitochondrial alpha-keto acid dehydrogenase complexes, molecular pathogenesis and structural basis of LADH deficiency, and relevant potential future medical perspectives.

Citing Articles

The Ubiquinone-Ubiquinol Redox Cycle and Its Clinical Consequences: An Overview.

Mantle D, Dewsbury M, Hargreaves I Int J Mol Sci. 2024; 25(12).

PMID: 38928470 PMC: 11203502. DOI: 10.3390/ijms25126765.

Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase.

Szabo E, Nemes-Nikodem E, Vass K, Zambo Z, Zrupko E, Torocsik B Int J Mol Sci. 2023; 24(13).

PMID: 37446004 PMC: 10341545. DOI: 10.3390/ijms241310826.

References

Ambrus A, Adam-Vizi V . Molecular dynamics study of the structural basis of dysfunction and the modulation of reactive oxygen species generation by pathogenic mutants of human dihydrolipoamide dehydrogenase. Arch Biochem Biophys. 2013; 538(2):145-55. DOI: 10.1016/j.abb.2013.08.015. View

Ambrus A, Adam-Vizi V . Human dihydrolipoamide dehydrogenase (E3) deficiency: Novel insights into the structural basis and molecular pathomechanism. Neurochem Int. 2017; 117:5-14. DOI: 10.1016/j.neuint.2017.05.018. View

Ambrus A, Tretter L, Adam-Vizi V . Inhibition of the alpha-ketoglutarate dehydrogenase-mediated reactive oxygen species generation by lipoic acid. J Neurochem. 2009; 109 Suppl 1:222-9. DOI: 10.1111/j.1471-4159.2009.05942.x. View

Ambrus A, Torocsik B, Tretter L, Ozohanics O, Adam-Vizi V . Stimulation of reactive oxygen species generation by disease-causing mutations of lipoamide dehydrogenase. Hum Mol Genet. 2011; 20(15):2984-95. DOI: 10.1093/hmg/ddr202. View

Ambrus A, Mizsei R, Adam-Vizi V . Structural alterations by five disease-causing mutations in the low-pH conformation of human dihydrolipoamide dehydrogenase (hLADH) analyzed by molecular dynamics - Implications in functional loss and modulation of reactive oxygen species generation.... Biochem Biophys Rep. 2018; 2:50-56. PMC: 5871931. DOI: 10.1016/j.bbrep.2015.04.006. View

Ambrus A, Nemeria N, Torocsik B, Tretter L, Nilsson M, Jordan F . Formation of reactive oxygen species by human and bacterial pyruvate and 2-oxoglutarate dehydrogenase multienzyme complexes reconstituted from recombinant components. Free Radic Biol Med. 2015; 89:642-50. PMC: 4684775. DOI: 10.1016/j.freeradbiomed.2015.10.001. View

Esther Babady N, Pang Y, Elpeleg O, Isaya G . Cryptic proteolytic activity of dihydrolipoamide dehydrogenase. Proc Natl Acad Sci U S A. 2007; 104(15):6158-63. PMC: 1851069. DOI: 10.1073/pnas.0610618104. View

Bando Y, Aki K . Mechanisms of generation of oxygen radicals and reductive mobilization of ferritin iron by lipoamide dehydrogenase. J Biochem. 1991; 109(3):450-4. DOI: 10.1093/oxfordjournals.jbchem.a123402. View

Barak N, Huminer D, Segal T, Ari Z, Halevy J, Tur-Kaspa R . Lipoamide dehydrogenase deficiency: a newly discovered cause of acute hepatitis in adults. J Hepatol. 1998; 29(3):482-4. DOI: 10.1016/s0168-8278(98)80069-x. View

10.

Benen J, Van Berkel W, Dieteren N, Arscott D, WILLIAMS Jr C, Veeger C . Lipoamide dehydrogenase from Azotobacter vinelandii: site-directed mutagenesis of the His450-Glu455 diad. Kinetics of wild-type and mutated enzymes. Eur J Biochem. 1992; 207(2):487-97. DOI: 10.1111/j.1432-1033.1992.tb17075.x. View

11.

Brassier A, Ottolenghi C, Boutron A, Bertrand A, Valmary-Degano S, Cervoni J . Dihydrolipoamide dehydrogenase deficiency: a still overlooked cause of recurrent acute liver failure and Reye-like syndrome. Mol Genet Metab. 2013; 109(1):28-32. DOI: 10.1016/j.ymgme.2013.01.017. View

12.

Brautigam C, Chuang J, Tomchick D, Machius M, Chuang D . Crystal structure of human dihydrolipoamide dehydrogenase: NAD+/NADH binding and the structural basis of disease-causing mutations. J Mol Biol. 2005; 350(3):543-52. DOI: 10.1016/j.jmb.2005.05.014. View

13.

Brautigam C, Wynn R, Chuang J, Machius M, Tomchick D, Chuang D . Structural insight into interactions between dihydrolipoamide dehydrogenase (E3) and E3 binding protein of human pyruvate dehydrogenase complex. Structure. 2006; 14(3):611-21. PMC: 2879633. DOI: 10.1016/j.str.2006.01.001. View

14.

Brautigam C, Wynn R, Chuang J, Chuang D . Subunit and catalytic component stoichiometries of an in vitro reconstituted human pyruvate dehydrogenase complex. J Biol Chem. 2009; 284(19):13086-98. PMC: 2676041. DOI: 10.1074/jbc.M806563200. View

15.

Brautigam C, Wynn R, Chuang J, Naik M, Young B, Huang T . Structural and thermodynamic basis for weak interactions between dihydrolipoamide dehydrogenase and subunit-binding domain of the branched-chain alpha-ketoacid dehydrogenase complex. J Biol Chem. 2011; 286(26):23476-88. PMC: 3123111. DOI: 10.1074/jbc.M110.202960. View

16.

Bunik V, Sievers C . Inactivation of the 2-oxo acid dehydrogenase complexes upon generation of intrinsic radical species. Eur J Biochem. 2002; 269(20):5004-15. DOI: 10.1046/j.1432-1033.2002.03204.x. View

17.

Cameron J, Levandovskiy V, MacKay N, Raiman J, Renaud D, Clarke J . Novel mutations in dihydrolipoamide dehydrogenase deficiency in two cousins with borderline-normal PDH complex activity. Am J Med Genet A. 2006; 140(14):1542-52. DOI: 10.1002/ajmg.a.31313. View

18.

Carrozzo R, Torraco A, Fiermonte G, Martinelli D, Di Nottia M, Rizza T . Riboflavin responsive mitochondrial myopathy is a new phenotype of dihydrolipoamide dehydrogenase deficiency. The chaperon-like effect of vitamin B2. Mitochondrion. 2014; 18:49-57. DOI: 10.1016/j.mito.2014.09.006. View

19.

cerna L, Wenchich L, Hansikova H, Kmoch S, Peskova K, Chrastina P . Novel mutations in a boy with dihydrolipoamide dehydrogenase deficiency. Med Sci Monit. 2001; 7(6):1319-25. View

20.

Ciszak E, Makal A, Hong Y, Vettaikkorumakankauv A, Korotchkina L, Patel M . How dihydrolipoamide dehydrogenase-binding protein binds dihydrolipoamide dehydrogenase in the human pyruvate dehydrogenase complex. J Biol Chem. 2005; 281(1):648-55. DOI: 10.1074/jbc.M507850200. View